Mr. Irakli Margvelashvili was invited to a live broadcast of TV Formula in connection with the review of current trends in the pharmaceutical segment and the planned changes in regulations.
Abovementioned interview can be seen on the link
Interview of the Executive Director of the Association, Irakli Margvelashvili, on the information portal geotimes.com.ge, regarding the issue of admission of medicines from Turkey to the Georgian market.
Abovementioned article, can be found at the link.
The speech of the Executive Director of the Association, Mr. Irakli Margvelashvili in the live broadcast of TV Formula, in the program "Morning Business", regarding the implementation of GMP and GDP standards.
Abovementioned interview can be seen at the link.
The speech of the Executive Director of the Association, Mr. Irakli Margvelashvili in the live broadcast of the First Channel, in the program "Business Partner"
Abovementioned interview can be seen at the link.
On December 17, at the invitation of the Drug Agency, the Executive Director of the Association, Mr. Irakli Margvelashvili, attended an event held at the Holiday Inn Hotel, where a 2-year report on the work of the Regulation Agency for Medical and Pharmaceutical Activities was presented.
The annual report of the National Health Agency was also presented at the event.
The event was opened by the Minister of Internally Displaced Persons from the Occupied Territories, Labor, Health and Social Affairs of Georgia.
Some interesting facts were presented in the presentations:
• The Professional Development Council held 33 sessions to discuss the activities of 308 physicians, and 274 physicians out of 308 physicians were assigned professional responsibilities;
• Accreditation was granted to 132 continuing medical education programs;
• Three sessions of doctors' certification and qualification exams were held;
• A new, more flexible and secure electronic examination system has been set up, which will be launched in 2022;
• Control over pharmaceutical activities has been increased: in 2021, 618 preliminary information-based inspections were conducted, and in 581 cases, activities were detected;
• In 2021, 86 cases of illegal pharmaceutical activities were revealed, 44,220 units worth 944,000 GEL worth of medicines were confiscated.
• The legality of psychotropic drugs was checked in 96 establishments and violations were identified in 1,601 prescribed prescriptions.
On December 14 and 15, our association attended an online council meeting of IFPMA (International Federation of Pharmaceutical Manufacturers and Associations), where IFPMA's 2021 Annual Report was presented.
Strategic priorities and the Equal Access Strategy, Reputation Survey and Communication Strategy for 2022 were also presented.
On December 10th, at the invitation of the Ministry of Health, our association participated in a workshop / seminar held with the support of the World Bank on health policy planning and implementation in the segments of drug pricing and procurement mechanisms.
The speakers at the seminar (international experts) shared their experiences from different countries.
APCRG members general meeting has accepted and validated membership request, submitted by the Representative Office of Novartis Pharma Services AG in Georgia. More information about the company and it's international operations can be seen on company website.
On December 7th a meeting was held at the Ministry of Health, chaired by
Minister of Health, Deputy Minister T. Gabunia and Head of the Drug Agency Z. Kapanadze.
Our association and associations of distributors and local manufacturers were invited from the private sector.
Meeting topic: Going to GMP and GDP standards.
The leadership of the Ministry has introduced some changes in the procedures for the transition to standards.
Most importantly, companies that have certificates of production or wholesale trade in January-May (different years) will have the opportunity to switch to the standards by June 30, 2022 (i.e. the transition deadline has been extended for these companies). As well as manufacturers who will not have GMP certificate, will be able to produce products only for export (not for the Georgian market) until 2025.
On June 16th, the Association of Pharmaceutical Companies Representatives in Georgia, participated in an online seminar organized by IFPMA, where IFPMA members were introduced to the new Regulatory Reliance Toolkit.
At this workshop, Policy Wisdom (IFPMA Partners) presented an overview of this toolkit designed specifically to regulate national-level capabilities. An extensive presentation was presented, which included the following issues:
Toolkit overview;
Introduction to Regulatory reliance
Regulatory reliance: concepts and application
Strategic approach to engagement
Monitoring the path to regulatory reliance